Adonis-brom (Tablets) Instructions for Use
Marketing Authorization Holder
Vifitech, CJSC (Russia)
ATC Code
C01AX (Other cardiac glycosides)
Dosage Form
| Adonis-brom | Coated tablets: 20 pcs. |
Dosage Form, Packaging, and Composition
Coated tablets yellow in color, round, biconvex.
| 1 tab. | |
| Thick extract of adonis (containing a sum of cardiac glycosides calculated as cymarin and absolutely dry substance 0.56 %) | 0.06907 g |
| Potassium bromide | 0.25 g |
10 pcs. – contour cell packaging (2) – cardboard packs.
25 pcs. – orange glass jars (1) – cardboard packs.
Clinical-Pharmacological Group
Sedative herbal preparation
Pharmacotherapeutic Group
Drugs for the treatment of heart diseases; cardiac glycosides; other cardiac glycosides
Pharmacological Action
It has a sedative, as well as a moderate cardiotonic effect.
Pharmacokinetics
No data available.
Indications
- Neurotic syndrome, incl. accompanied by tachycardia.
ICD codes
| ICD-10 code | Indication |
| F45.3 | Somatoform dysfunction of the autonomic nervous system |
| F48.0 | Neurasthenia |
| F48.9 | Unspecified neurotic disorder |
| R00.0 | Tachycardia, unspecified (including nodal (sinus) NOS) |
| ICD-11 code | Indication |
| 6A8Z | Affective disorders, unspecified |
| 6B6Z | Dissociative disorders, unspecified |
| 6C20.Z | Bodily distress disorder, unspecified |
| MC81.Z | Abnormalities of heart rhythm, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer the tablets orally.
Take one tablet three times daily.
Always take the dose after meals to improve tolerability.
The standard course of treatment is 25 to 30 days.
Do not initiate a repeated course without consulting a physician; the advisability of further treatment must be determined by a doctor based on clinical assessment.
Monitor for potential adverse effects, particularly with prolonged use.
Adhere strictly to the prescribed dosage and duration to minimize the risk of bromide accumulation.
Adverse Reactions
Possible allergic reactions, nausea, vomiting; with long-term use – cough, runny nose, apathy, general weakness, impaired perception, memory loss, skin rash, conjunctivitis.
Contraindications
- Severe bradycardia;
- AV block of varying degrees;
- Morgagni-Adams-Stokes syndrome;
- Angina pectoris;
- Erosions;
- Ulcers of the esophagus, stomach and duodenum;
- Sucrase/isomaltase deficiency;
- Fructose intolerance;
- Glucose-galactose malabsorption;
- Pregnancy;
- Lactation;
- The drug is not recommended for use in children under 18 years of age due to lack of data on efficacy and safety;
- Hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
It is not recommended for use during pregnancy and lactation due to the lack of specific data on safety of use in this category of patients.
Pediatric Use
The drug is not recommended for use in children under 18 years of age due to lack of data on efficacy and safety.
Special Precautions
Patients with diabetes should take into account that 1 tablet of the drug contains about 0.263 g of carbohydrates (0.022 XE).
Effect on ability to drive vehicles and operate machinery
With long-term use of the drug in large doses, a decrease in the speed of psychomotor reactions is possible, which should be taken into account when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
Overdose
Symptoms of bromide overdose cough, runny nose, apathy, headache, general weakness, impaired perception, memory loss, skin rash, conjunctivitis.
Treatment it is necessary to discontinue the drug, administer large amounts (in the absence of contraindications) of sodium chloride – 10-20 g/day (accelerates the excretion of bromine) in combination with plenty of fluids (3-5 l/day).
Symptoms of cardiac glycoside overdose severe bradycardia, polytopic extrasystole, bigeminy or trigeminy, slowing of atrioventricular conduction; in severe cases – ventricular flutter and cardiac arrest.
Treatment a break in their use, if necessary, potassium preparations and antiarrhythmic agents are prescribed.
Drug Interactions
The drug enhances the effect of hypnotics and other drugs that depress the CNS, which requires dose adjustment when used concomitantly.
Storage Conditions
Store the drug in a dry, light-protected place at a temperature not exceeding 25°C (77°F). Keep out of reach of children.
Shelf Life
Shelf life – 2 years.
Do not use after the expiration date.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer